The estimated Net Worth of Raquel C. Bono is at least $130 Tysiąc dollars as of 4 September 2021. Raquel Bono owns over 397 units of Humana stock worth over $130,291 and over the last 4 years he sold HUM stock worth over $0. In addition, he makes $0 as Independent Director at Humana.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Raquel Bono HUM stock SEC Form 4 insiders trading
Raquel has made over 1 trades of the Humana stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 397 units of HUM stock worth $130,291 on 4 September 2021.
The largest trade he's ever made was exercising 397 units of Humana stock on 4 September 2021 worth over $130,291. On average, Raquel trades about 66 units every 0 days since 2020. As of 4 September 2021 he still owns at least 397 units of Humana stock.
You can see the complete history of Raquel Bono stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Raquel Bono biography
Dr. Raquel Bono serves as Independent Director of the Company. Dr. Bono served as the Chief Executive Officer and Director for the Defense Health Agency (DHA), the joint, integrated combat support agency that enables all branches of the U.S. military medical services to provide health care to combatant commands. That post capped a military career during which Dr. Bono became known in the halls of the Pentagon, Congress and Executive Branch as a highly accomplished leader with high integrity. During her tenure with the DHA, Dr. Bono integrated an unprecedented $50 billion worldwide health care enterprise for the Army, Navy, Air Force and Marine Corps, comprised of 50 hospitals and 300 clinics that provide care to more than nine million military personnel. She oversaw the Department of Defense deployment of electronic health records and facilitated the collaboration between the largest federated health systems of the Department of Defense and Department of Veterans Affairs (VA). Dr. Bono began her career with active duty deployment in Operations Desert Shield and Desert Storm and served in various roles with the Navy and TRICARE prior to joining DHA, including serving as Chief Executive Officer of a large military hospital.
What's Raquel Bono's mailing address?
Raquel's mailing address filed with the SEC is HUMANA INC., 500 W MAIN STREET, LOUISVILLE, KY, 40202.
Insiders trading at Humana
Over the last 21 years, insiders at Humana have traded over $407,571,978 worth of Humana stock and bought 48,042 units worth $3,529,357 . The most active insiders traders include Brad D Smith, Frank A Damelio oraz Frank Bisignano. On average, Humana executives and independent directors trade stock every 12 days with the average trade being worth of $6,532,294. The most recent stock trade was executed by George Ii Renaudin on 1 September 2024, trading 1,241 units of HUM stock currently worth $407,284.
What does Humana do?
at humana, our cultural foundation is aligned to helping members achieve their best health by delivering personalized, simplified, whole-person healthcare experiences. recognizing healthcare needs continue to evolve for each person, for each family and for each community, humana continuously creates innovative solutions and resources that help people live their healthiest lives on their terms –when and where they need it. our employees are at the heart of making this happen and that’s why we are dedicated to building an organization of dynamic talent whose experience and passion center on putting the customer first.
What does Humana's logo look like?
Complete history of Raquel Bono stock trades at Humana
Humana executives and stock owners
Humana executives and other stock owners filed with the SEC include:
-
Bruce Broussard,
President, Chief Executive Officer, Director -
Brian Kane,
Chief Financial Officer -
Bruce Dale Broussard,
Pres, CEO & Director -
Christopher Hunter,
Segment President, Group and Military Business -
Alan Wheatley,
Segment President - Retail -
Timothy Huval,
Chief Administrative Officer -
William Fleming,
Segment President, Clinical and Pharmacy Solutions -
Timothy S. Huval,
Chief Admin. Officer -
T. Alan Wheatley,
Segment Pres of Retail -
Dr. William Kevin Fleming Pharm.D., PharmD, RPh,
Chief Corp. Affairs Officer & Segment Pres, Pharmacy Solutions -
Kurt Hilzinger,
Independent Chairman of the Board -
David Jones,
Independent Director -
James O'Brien,
Independent Director -
Frank Bisignano,
Independent Director -
William McDonald,
Independent Director -
Karen Katz,
Independent Director -
Frank D'Amelio,
Independent Director -
Marissa Peterson,
Independent Director -
Amy Smith,
Vice President, Investor Relations -
John Garratt,
Independent Director -
Wayne Frederick,
Independent Director -
Raquel Bono,
Independent Director -
Joseph Ventura,
Chief Legal Officer -
William Shrank,
Chief Medical and Corporate Affairs Officer -
Heather Carroll,
Chief Digital Health and Analytics Officer -
Vishal Agrawal,
Chief Strategy and Corporate Development Officer -
Sam Deshpande,
Chief Technology Officer, Chief Risk Officer -
Cynthia Zipperle,
Senior Vice President, Chief Accounting Officer, Controller -
Susan Diamond,
Segment President, Home Business -
Joseph C. Ventura,
Chief Legal Officer -
Lisa M. Stoner,
VP of Investor Relations -
Sam M. Deshpande,
Chief Information Officer -
Cynthia Hillebrand Zipperle,
Sr. VP, Chief Accounting Officer & Controller -
Susan Marie Diamond,
CFO & Segment Pres of Home Bus. -
Amy Fry,
Sr. VP of Corp. Communications -
Michael A. Koeberlein,
SVP, Chief Accting Off & Cont. -
Heather Cox,
Chief Dig Health & Analyt Off. -
Christopher E Kay,
SVP & Chief Innovation Officer -
Webster Roy Dunbar,
Director -
James E Murray,
COO-Mkt & Bus. Segment Ops -
Roy A Beveridge,,
Sr. VP & Chief Medical Officer -
Joseph William Jasser,
President, Care Delivery -
M Todoroff Christopher,
Sr. VP and General Counsel -
Jody L Bilney,
Chief Consumer Officer -
Heidi S Margulis,
Senior V.P.-Gov. Relations -
Steven E Mc Culley,
Vice President & Controller -
David Nash,
Director -
William Mitchell,
Director -
Karen B De Salvo,
Director -
Jorge S. Mesquita,
Director -
Marcy S Klevorn,
Director -
Thomas J Liston,
Sr VP-Strategy & Corp Dev -
Michael B Mccallister,
President & CEO -
Elizabeth D Bierbower,
Strategic Advisor -
James H Bloem,
Sr. VP, CFO & Treasurer -
Bruce D Perkins,
Sgmnt Pres, Health&Well-Being -
Tim S Mc Clain,
Group Pres, Govt & Other Busin -
Paul B. K. Kusserow,
Sr VP & Ch Strat Dev Officer -
Venkata R Madabhushi,
SVP & Chief Innov & Mrkting Of -
Bonnie C Hathcock,
Sr VP & Chief Human Res. Off -
W Ann Reynolds,
Director -
Jonathan T Md Lord,
Sr VP & Chief Innovation Off. -
Bruce J Goodman,
Sr VP & Chief Serv. & Info. Of -
Kathleen Pellegrino,
VP and Acting General Counsel -
James O Robbins,
Director -
Steven O Moya,
Sr. VP-Chief Marketing Officer -
Arthur P Hipwell,
Sr VP & General Counsel -
John M Bertko,
Vice President & Chief Actuary -
Michael E Gellert,
Director -
David A Sr/Ky Jones,
Director -
John R /Ky Hall,
Director -
R Eugene Shields,
Senior Vice President-Gov Prgm -
Irwin Lerner,
Director -
Brian P. Le Claire,
Strategic Advisor -
Susan D. Schick,
Seg Pres. Grp. & Military Bus. -
David T Feinberg,
Director -
M.D. Andrew C. Agwunobi,,
Seg. President, Home Solutions -
John Paul W. Felter,
SVP, Chief Accting Off & Cont. -
Brad D Smith,
Director -
George Ii Renaudin,
President, Medicare & Medicaid -
Sanjay K Shetty,
President, CenterWell -
David Dintenfass,
President, Enterprise Growth -
James A. Rechtin,
President & COO